Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products

3Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

G-6-P synthase enzyme has been involved in the synthesis of the microbial cell wall, and its inhibition may lead to the antimicrobial effect. In the present study, we designed a library of amygdalin derivatives, and two most active derivatives selected on the basis of various parameters viz. dock score, binding energy, and ADMET data using molecular docking software (Schrodinger’s Maestro). The selected derivatives were synthesized and evaluated for their antioxidant and antimicrobial potential against several Gram (+ ve), Gram (−ve), as well as fungal strains. The results indicated that synthesized compounds exhibited good antioxidant, antimicrobial, and better preservative efficacy in food preparation as compared to the standard compounds. No significant differences were observed in different parameters as confirmed by Kruskal–Wallis test (p < 0.05). Docking results have been found in good correlation with experimental wet-lab data. Moreover, the mechanistic insight into the docking poses has also been explored by binding interactions of amygdalin derivative inside the dynamic site of G-6-P synthase.

Cite

CITATION STYLE

APA

Lather, A., Sharma, S., & Khatkar, A. (2020). Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-70895-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free